SynOV1.1 Intratumoral Injection Study

Clinical trial NCT04612504 · UNKNOWN

Trial details

NCT number: NCT04612504
Sponsor: Beijing Syngentech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2022-06-23
Primary completion: 2023-12-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.